两例由THRA突变所致甲状腺激素抵抗新病例
报告两例由THRA基因错义突变(M259T、T273A)所致甲状腺激素抵抗α(RTHα)新病例;结合生化与细胞实验及计算机模拟,发现M259T(T273A程度较轻)降低TRα1对三碘甲状腺原氨酸(T3)的亲和力,其负效应仅能被大量过量T3逆转;两例RTHα严重程度与TRα1突变体对T3亲和力下降及T3存在下辅阻遏物不能解离相关。
要点
- 报告两例RTHα新病例,分别携带THRA错义突变M259T和T273A。
- M259T及程度较轻的T273A降低TRα1对T3的亲和力,仅大量过量T3可逆转其负效应。
- 两例RTHα的严重程度与TRα1突变体对T3亲和力下降及辅阻遏物不能解离相关。
核心结论
- 两例新RTHα病例的严重程度源于TRα1突变体对T3结合亲和力下降,并与T3存在下辅阻遏物不能从TRα1突变体解离相关。
研究设计与样本
- 报告两例携带THRA错义突变(M259T、T273A)的RTHα患者,结合生化与细胞实验及计算机模拟评估突变体TRα1功能。
主要发现
- M259T及程度较轻的T273A降低TRα1对T3的亲和力。
- M259T与T273A的负效应仅被大量过量T3逆转。
- 两例RTHα的严重程度与TRα1突变体对T3结合亲和力下降及辅阻遏物不能解离相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Resistance to thyroid hormone alpha (RTHα) is a rare and under-recognized genetic disease caused by mutations of THRA, the gene encoding thyroid hormone receptor α1 (TRα1). We report here two novel THRA missense mutations (M259T, T273A) in patients with RTHα. We combined biochemical and cellular assays with in silico modeling to assess the capacity of mutant TRα1 to bind triiodothyronine (T3), to heterodimerize with RXR, to interact with transcriptional coregulators, and to transduce a T3 transcriptional response. M259T, and to a lower extent T273A, reduces the affinity of TRα1 for T3. Their negative influence is only reverted by large excess of T3. The severity of the two novel RTHα cases originates from a reduction in the binding affinity of TRα1 mutants to T3 and thus correlates with the incapacity of corepressors to dissociate from TRα1 mutants in the presence of T3.
引用
- le Maire A, Bouhours-Nouet N, Soamalala J, et al. Two Novel Cases of Resistance to Thyroid Hormone Due to THRA Mutation. Thyroid. 2020. PMID: 32204686. doi:10.1089/thy.2019.0602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。